Urology Robotic Surgery Market Report 2025

The urology robotic surgery market size has grown rapidly in recent years. It will grow from $4.37 billion in 2024 to $4.94 billion in 2025 at a compound annual growth rate (CAGR) of 13%. Growth during the historic period was driven by the rising incidence of urological disorders, an increasing preference for minimally invasive surgeries, a growing geriatric population, expansion of hospital infrastructure, and higher healthcare expenditure.

The urology robotic surgery market size is expected to see rapid growth in the next few years. It will grow to $7.96 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. Growth in the forecast period is expected to be fueled by increasing demand for outpatient urology procedures, the rise of medical tourism in emerging markets, greater awareness of the benefits of robotic surgery, growing government initiatives to promote advanced healthcare, and an increasing focus on improving patient outcomes. Key trends anticipated during this period include technological advancements in urology surgery, innovations in surgical robotics, increased investment in research and development, the development of compact robotic systems, and the integration of artificial intelligence into surgical procedures.

The rising prevalence of urological disorders is expected to drive the growth of the urology robotic surgery market in the coming years. Urological disorders are conditions that affect the urinary tract and male reproductive organs. The increase in these disorders is primarily linked to an aging population, as advancing age weakens bladder and pelvic muscles, raising the likelihood of such conditions. Urology robotic surgery provides precise, minimally invasive treatment options that improve surgical accuracy, reduce complications, and enhance recovery for conditions such as prostate cancer and kidney disease. For instance, in January 2025, Prostate Cancer UK, a UK-based charitable organization, reported that in England, 50,751 men were diagnosed with prostate cancer in 2022, increasing to 55,033 in 2023. Therefore, the growing prevalence of urological disorders is fueling the expansion of the urology robotic surgery market.

Companies in the urology robotic surgery market are focusing on incorporating artificial intelligence (AI)-powered features to improve surgical precision and outcomes. AI applications in urology robotic surgery include real-time image guidance for tumor detection, surgical planning using 3D models, and intraoperative skill assessment, all aimed at enhancing accuracy and efficiency. For example, in August 2024, PROCEPT BioRobotics, a US-based surgical robotics company, received FDA clearance for the HYDROS Robotic System, an AI-powered platform designed to improve Aquablation therapy for benign prostatic hyperplasia (BPH). The system integrates AI-driven treatment planning, next-generation imaging, and robotic-assisted, heat-free waterjet tissue resection to accurately and efficiently remove prostate tissue while preserving critical anatomical structures. It also streamlines surgical workflows and enhances operating room efficiency. HYDROS aims to provide consistent, personalized, and durable symptom relief with improved preservation of sexual and urinary function, representing a major advancement in BPH treatment.

In August 2024, KARL STORZ SE & Co. KG, a Germany-based provider of endoscopy equipment and minimally invasive surgical solutions, acquired Asensus Surgical, Inc. for an undisclosed amount. This acquisition is intended to integrate Asensus Surgical’s innovative digital laparoscopic platform into the KARL STORZ portfolio, enhancing surgical precision, intelligence, and workflow efficiency in operating rooms worldwide. Asensus Surgical Inc. is a US-based medical device company that offers robotic surgery for urology through its Senhance Surgical System.

Major players in the urology robotic surgery market are Siemens Healthineers, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical Inc., KARL STORZ SE & Co. KG, Sina Robotics and Medical Innovators Co. Ltd., CMR Surgical Limited, SS Innovations International Inc., Distalmotion SA, Ronovo Surgical Inc., Levita Magnetics International Corp., Titan Medical Inc., Virtual Incision Corporation, Nanjing Perlove Medical Equipment Co. Ltd., Edge Medical Robotics Corporation, Rob Surgical Systems S.L, Virtuoso Surgical Inc., GynoBotics Inc., Harbin Sagebot Intelligent Medical Equipment Co. Ltd., and Perlove Medical Robot.

North America was the largest region in the urology robotic surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urology robotic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the urology robotic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Urology robotic surgery is a minimally invasive technique in which advanced robotic systems assist urologists in performing precise procedures through small incisions. The surgeon operates robotic arms from a console, benefiting from enhanced dexterity and three-dimensional visualization, which minimizes damage to surrounding tissues. This method is commonly used to treat conditions such as prostate, kidney, and bladder cancers.

The primary types of urology robotic surgery include robot machines, navigation systems, planners, simulators, and others. Robotic surgery systems are sophisticated machines designed to support surgeons in carrying out highly accurate urological procedures. These systems comprise robotic platforms, instruments and accessories, and related services, with applications in robotic prostatectomy, robotic cystectomy, robotic pyeloplasty, robotic nephrectomy, and other procedures. The key end users include hospitals, ambulatory surgical centers, specialty clinics, and others.

The urology robotic surgery market research report is one of a series of new reports that provides urology robotic surgery market statistics, including urology robotic surgery industry global market size, regional shares, competitors with a urology robotic surgery market share, detailed urology robotic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the urology robotic surgery industry. This urology robotic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urology robotic surgery market includes revenues earned by entities by providing services such as preoperative planning, intraoperative imaging, robotic system maintenance, remote surgical assistance, and training and education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The urology robotic surgery market also consists of sales of products, such as surgical visualization systems, haptic feedback devices, robotic arm components, sterile drapes, and software integration tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.